Type 2 Diabetes Trial, Recruiting NCT06067139 Sponsor: Kaiser Permanente Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT06067139
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 22 and 79 years old
  • You have been told you have prediabetes (blood sugar levels higher than normal, but not yet diabetes)
  • You have insomnia (ongoing trouble falling or staying asleep)
  • You have regular access to a device with internet (such as a smartphone, tablet, or computer)
  • You have enough health information available at the start of the study to meet the study's data requirements (confirm with trial site)

Who may not be able to join:

  • Your body mass index (a measure of weight relative to height) is over 40
  • You have other sleep-related health conditions noted in your medical records or history
  • You work night shifts or have an unpredictable sleep schedule imposed by outside factors
  • You are found to have moderate to severe sleep apnea (breathing interruptions during sleep) based on a sleep test done as part of this trial
  • You have already completed a full course of a specific talking therapy for insomnia called CBT-I in the last 12 months
  • You are currently taking medications that affect blood sugar levels
  • You have a history of type 1 or type 2 diabetes, or are currently using or planning to use blood sugar-lowering medicines (such as metformin or insulin)
  • You have had weight-loss surgery in the recent past or are planning to have it within the next year
  • You are currently or recently using prescription weight-loss medications
  • Your sleep medication type or dose has changed recently
  • You have a serious health condition that could make it difficult or risky to take part in the therapy used in this study
  • You are unwilling or unable to avoid operating heavy machinery or driving for long periods, or you have an unstable illness that could be made worse by temporarily limiting sleep
  • You are considered at high risk of falling
  • You have epilepsy
  • You have certain medical conditions that could interfere with the study's therapy or contribute to sleep or blood sugar problems — for example, an overactive thyroid, significant kidney disease, active cancer treatment, or any condition requiring long-term steroid use
  • You have a significant alcohol or substance use disorder
  • You have an active or recent history of an eating disorder, or your weight has changed by more than 10% recently
  • You are currently pregnant, planning to become pregnant, breastfeeding, or less than one year since giving birth (for women)
  • You use a medication called hydroxyurea
  • You have significant skin problems or an allergy to adhesives that would make wearing a small glucose monitoring sensor on your skin difficult

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Erin LeBlanc, MD, Kaiser Permanente

Phone: 971-232-9343

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Kaiser Permanente
Registry
ClinicalTrials.gov
Start date
1 August 2023
Est. completion
1 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

2-hour post-load glucose (2hPG) (mg/dL)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov